One year after ending War in Afghanistan, US spy agencies pivot toward China August 8, 2022 5:40 pm|WASHINGTON (AP) — In a recent closed-door meeting with leaders of the agency’s counterterrorism center, the CIA’s No.…
SHAREHOLDER ALERT: Weiss Law Investigates Professional Holding Corp. August 8, 2022 5:39 pm|NEW YORK, Aug. 8, 2022 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations…
Hot Fill Packaging Demand for Sauces & Condiments to See Strongest Growth August 8, 2022 5:37 pm|CLEVELAND, Aug. 8, 2022 /PRNewswire/ — Sauces and condiments – the largest application for hot fill packaging –…
NATWEST GROUP PLC AND NATWEST MARKETS N.V. – PRICING OF SEPARATE CASH TENDER OFFERS FOR CERTAIN OF THEIR RESPECTIVE OUTSTANDING NOTES August 8, 2022 5:36 pm|LONDON, Aug. 8, 2022 /PRNewswire/ — NatWest Group plc (“NatWest Group“) and NatWest Markets N.V. (“NWM N.V.“) (each an…
Latex glove factory opens up hundreds of jobs in Eufaula August 8, 2022 5:35 pm|EUFAULA, Ala. (WTVM) – Hundreds of new jobs are coming to East Alabama. Production started today at a…
Alex Jones’ texts turned over to Jan. 6 panel, source says August 8, 2022 5:33 pm|(CNN) – The Jan. 6 House select committee now has about two years’ worth of text messages sent…
7 Chattahoochee Valley suspects among 22 indicted in alleged drug ring August 8, 2022 5:28 pm|COLUMBUS, Ga. (WTVM) – Several people from the Chattahoochee Valley face multiple drug trafficking charges following a federal…
MasTec, Inc. Announces Commencement of Exchange Offer and Consent Solicitation August 8, 2022 5:24 pm|CORAL GABLES, Fla., Aug. 8, 2022 /PRNewswire/ — MasTec, Inc. (NYSE: MTZ) (the “Company“) announced its commencement of…
SHAREHOLDER ALERT: Weiss Law Investigates Avalara, Inc. August 8, 2022 5:22 pm|NEW YORK, Aug. 8, 2022 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations of…
Inhibrx Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights August 8, 2022 5:19 pm|SAN DIEGO, Aug. 8, 2022 /PRNewswire/ — Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs…